Fate of Iowa's medical marijuana industry remains hazy
DES MOINES, Ia (AP) —
Serious questions linger about the fate of medical marijuana in Iowa as lawmakers find themselves considering an eleventh-hour deal that would expand the program to more patients.
Executives at MedPharm Iowa, the state's sole manufacturer of medical cannabis oil, worry many patients will find treatment to be unaffordable, impractical or obtainable due to restrictions placed on the fledgling industry. The company wants to see legislators remove a limit on THC, the most psychoactive compound in marijuana.
A bill with uncertain fate is pending in the Republican-controlled Legislature as legislative leaders focus on the state budget and tax cuts.
House Speaker Linda Upmeyer, a Clear Lake Republican, says she would rather consider any changes to medical marijuana next year. MedPharm Iowa says that would hurt some potential patients.